Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells totreatment with gefitinib
- Authors
- Morgillo, Floriana; Kim, Woo-Young; Kim, Edward S.; Ciardiello, Fortunato; Hong, Waun Ki; Lee, Ho-Young
- Issue Date
- May-2007
- Publisher
- AMER ASSOC CANCER RESEARCH
- Citation
- CLINICAL CANCER RESEARCH, v.13, no.9, pp 2795 - 2803
- Pages
- 9
- Journal Title
- CLINICAL CANCER RESEARCH
- Volume
- 13
- Number
- 9
- Start Page
- 2795
- End Page
- 2803
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/148431
- DOI
- 10.1158/1078-0432.CCR-06-2077
- ISSN
- 1078-0432
1557-3265
- Abstract
- Purpose: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors have been found to be effective against lung cancer in vitro, but clinical resistance to these agents has developed as their usage has increased. In this study, we determined whether the insulin-like growth factor I (IGF-1) signaling pathway induces resistance of non-small cell lung cancer (NSCLC) cells to the EGFR tyrosine kinase inhibitor gefitinib.Experimental Design: The effects of gefitinib and cetuximab on NSCLC cells, alone or with an IGF-1 receptor (IGF-IR) inhibitor, were assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, the flow cytometry-based terminal nucleotidyl transferase-mediated nick end labeling assay, coimmunoprecipitation, and Western blot analysis. EGFR and IGFR expression in NSCLC tissues were examined by Western blot analysis.
Results: Gefitinib inhibited NSCLC cell proliferation by inducing apoptosis when IGF-IR signaling was suppressed. Treatment with gefitinib, but not cetuximab, induced EGFR: IGF-IR heterodimerization and activation of IGF-IR and its downstream signaling mediators, resulting in increased survivin expression in NSCLC cell lines with high levels of IGF-IR expression. Inhibition of IGF-IR activation and knockdown of survivin expression led to increased apoptos
- Files in This Item
-
Go to Link
- Appears in
Collections - 약학대학 > 약학부 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/148431)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.